Affiliation
Christie NHS Foundation Trust, Manchester, UKIssue Date
2015-10
Metadata
Show full item recordCitation
PD-L1 expression as a potential predictive biomarker. 2015, 16 (13):1285-7 Lancet OncolJournal
Lancet OncologyDOI
10.1016/S1470-2045(15)00307-1PubMed ID
26433815Type
ArticleLanguage
enISSN
1474-5488ae974a485f413a2113503eed53cd6c53
10.1016/S1470-2045(15)00307-1
Scopus Count
Collections
Related articles
- Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer.
- Authors: Cagle PT, Bernicker EH
- Issue date: 2015 Dec
- [PD-L1 expression: An emerging biomarker in non-small cell lung cancer].
- Authors: Adam J, Planchard D, Marabelle A, Soria JC, Scoazec JY, Lantuéjoul S
- Issue date: 2016 Jan
- PD-L1 and immune escape: insights from melanoma and other lineage-unrelated malignancies.
- Authors: Frydenlund N, Mahalingam M
- Issue date: 2017 Aug
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
- Authors: McLaughlin J, Han G, Schalper KA, Carvajal-Hausdorf D, Pelekanou V, Rehman J, Velcheti V, Herbst R, LoRusso P, Rimm DL
- Issue date: 2016 Jan
- [Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study].
- Authors: Scheel AH, Dietel M, Heukamp LC, Jöhrens K, Kirchner T, Reu S, Rüschoff J, Schildhaus HU, Schirmacher P, Tiemann M, Warth A, Weichert W, Fischer RN, Wolf J, Büttner R
- Issue date: 2016 Nov